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ABSTRACT Functionalized quantum dots offer several advantages for tracking the motion of individual molecules on the cell
surface, including selective binding, precise optical identiﬁcation of cell surface molecules, and detailed examination of the
molecularmotion without photobleaching.We have used quantum dots conjugatedwith integrin antibodies and performed studies
to quantitatively demonstrate changes in the integrin dynamics during osteogenic differentiation of human bone marrow derived
progenitor cells (BMPCs). Consistent with the unusually strong BMPC adhesion previously observed, integrins on the surface of
undifferentiated BMPC were found in clusters and the lateral diffusion was slow (e.g., ;1011 cm2/s). At times as early as those
after a 3-day incubation in the osteogenic differentiation media, the integrin diffusion coefﬁcients increased by an order of
magnitude, and the integrin dynamics became indistinguishable from that measured on the surface of terminally differentiated
human osteoblasts. Furthermore, microﬁlaments in BMPCs consisted of atypically thick bundles of stress ﬁbers that were
responsible for restricting the integrin lateral mobility. Studies using laser optical tweezers showed that, unlike fully differentiated
osteoblasts, theBMPCcytoskeleton isweakly associatedwith its cell membrane. Based on these ﬁndings, it appears likely that the
altered integrin dynamics is correlated with BMPC differentiation and that the integrin lateral mobility is restricted by direct links to
microﬁlaments.
INTRODUCTION
Regulation of bone marrow derived progenitor cell (BMPC)
differentiation offers exciting possibilities for numerous bio-
medical and clinical applications. There are now focused
research efforts directed at the manipulation and control of
cell differentiation. These progenitor cells have the unique
property of self-renewal without differentiation until and un-
less appropriate biological and physical signals are provided.
When applied to tissue engineering, for example, the use of
BMPCs would offer numerous advantages, including pro-
liferative and regenerative capability. Successful progenitor
cell-based tissue engineering and regenerative medicine ap-
plications will require the cells to properly adhere to sub-
strate. Whereas cell adhesion involves several classes of
specialized proteins such as integrins, cadherins, and selec-
tins, the cell-substrate adhesion (e.g., focal adhesion) is pri-
marily mediated by integrins that are composed of two
noncovalently bound a and b subunits (1–3). In a focal ad-
hesion contact, integrins provide a structural function by
physically linking microﬁlaments to the extracellular envi-
ronment. Integrins not only mediate cell adhesion but also
participate in the cell activation and signaling that initiate
signal transduction cascades through the integrin’s cytoplas-
mic domain (4). Further, in addition to the critical role in
formation of focal adhesions, integrins have been identiﬁed
to mediate cell proliferation, differentiation, migration, and
apoptosis (5–7). Moreover, integrins are essential for normal
development of hematopoietic lineages and bone marrow
by regulating cell proliferation and differentiation (8), and
the cardiomyocyte cell cycle depends on cell attachment via
integrins (9).
The integrin expression level is often associated with cell
differentiation. For example, neuronal differentiation in-
volves downregulation of integrins (10) and, at successive
stages of the osteoblast lineages, cells show differential pat-
terns of integrin expression (11). Although the molecular
characterization of integrin expression and pattern has been
correlated with cell differentiation, it remains to be eluci-
dated whether biophysical characterization of the integrin
dynamics on the BMPC surface is dependent on the different
stages of cell differentiation. For instance, because integrin
diffusion to the cell-substrate contact sites is believed to reg-
ulate cell adhesion strength (12), the integrin lateral mobility
on the cell surface may also correlate with cell differenti-
ation. It appears that highly motile cells form weak focal
adhesion contacts, and an inverse correlation has been es-
tablished between cell adhesion and cell migration (13).
Although the role of integrins involved in cell differentiation
has been extensively examined (14–17), changes in the
integrin diffusion characteristics at the successive stages of
BMPC differentiation have not been determined.
The integrin dynamics could be determined using several
biophysical techniques. For example, the ﬂuorescence recov-
ery after photobleaching (FRAP) technique has been used
to measure the integrin lateral mobility (2,18,19). Whereas
FRAP is a useful technique to measure the average integrin
Submitted August 7, 2006, and accepted for publication October 17, 2006.
Address reprint requests to Dr. Michael Cho, Dept. of Bioengineering,
University of Illinois, Chicago, 851 S. Morgan St. (M/C 063), Chicago, IL
60607. Tel.: 312-413-9424; Fax: 312-996-5921; E-mail: mcho@uic.edu.
 2007 by the Biophysical Society
0006-3495/07/02/1399/10 $2.00 doi: 10.1529/biophysj.106.094896
Biophysical Journal Volume 92 February 2007 1399–1408 1399
dynamics over a distance of micrometer range, advanced
optical techniques such as single particle tracking (SPT),
which incorporates nanometer-sized gold beads, have been
applied to measure the motions of individual cell surface
receptors with nanometer precision (20,21). In addition, be-
cause the temporal resolution is similar, the diffusion co-
efﬁcients that are two orders of magnitude smaller (e.g.,
microdiffusion) than those determined by FRAP can be
detected (22). Using 40-nm gold beads to label integrin
molecules, the role of the integrin cytoplasmic tail and its
interaction with cytoskeleton has been demonstrated. For
example, a4-integrins (CD49d) were found to diffuse at the
rate of 3 3 1010 cm2/s on the surface of Chinese hamster
ovary cell but, more importantly, deletion of the a4-integrin
tail induced impaired cell adhesion and more than a three-
fold reduction in the diffusion coefﬁcient (23). This ﬁnding
suggests a critical role of a4 integrins in formation of focal
adhesion sites and physical attachment to cytoskeleton. Fur-
ther, liganded b1-integrins (e.g., CD29) were shown to attach
to the cytoskeleton, and deletion of the b1-integrin cyto-
plasmic tail prevented cytoskeletal attachment, indicating
that selective ligand binding may be the critical step in reg-
ulating cell surface receptor movement and subsequent cell
migration (24).
Recently, semiconductor nanocrystal quantum dots have
been successfully used to track single protein dynamics (25,
26). Quantum dots have several advantages over gold beads
and conventional ﬂuorescent dyes. First, quantum dots may
be used as a ﬂuorescent probe to selectively label and mon-
itor the nanoscale protein movement without the extensive
image manipulation and analysis that are typically required
of the phase-contrast gold bead images. Second, these nano-
crystals are resistant to photobleaching and therefore provide
much improved temporal stability (27,28). Third, unlike con-
ventional ﬂuorophores, only a small fraction of the receptors
of interest can be labeled with functionalized quantum dots
and yet provide sufﬁciently large signal/noise ratios to track,
monitor, and identify subcellular processes in real-time.
Quantum dots were also successfully used to characterize
and automate cell motility and migration (29).
As reported by many authors, stem cells and BMPCs have
unique structural, mechanical, and biochemical properties,
which are quite different from those of fully differentiated
cells (30,31). Mechanical properties such as cytoskeleton or-
ganization and elasticity, membrane tension, cell shape, and
adhesion strength may play an important role in cell fate and
differentiation (32) and could be correlated with integrin-
dependent adhesion. In this study we used antibody-conju-
gated CdSe quantum dots to characterize the integrin diffusion
on the surface of BMPCs at the successive stages of os-
teogenic differentiation at days 1, 3, 7, 10, and 14 and
optically measured the cellular mechanics using laser optical
tweezers (LOT). Integrins were found to diffuse slowly on the
surface of undifferentiated BMPCs but, after times as early
as those after a 3-day incubation in osteogenic differentiation
media, integrins were able to undergo rapid lateral diffusion.
The integrin lateral mobility constraints were removed by
disrupting microﬁlaments. The LOT measurements showed
that, whereas the terminally differentiated osteoblasts
exhibited tightly bound cell membrane with the underlying
cytoskeleton, the undifferentiated BMPC membrane was
weakly associated with the cytoskeleton. These ﬁndings
suggest that, together with the membrane properties, integrin
lateral mobility may reﬂect and correlate with the state of
BMPC proliferation and differentiation and that the actin-
based cytoskeletal organization is largely responsible for




Human BMPCs were obtained from the Tulane Center for Gene Therapy
(New Orleans, LA). Based on the ﬂow cytometry results, these progenitor
cells showed negative staining for CD34, CD36, CD45, and CD117 markers
(all ,2%) and positive staining for CD44, CD90, CD166, CD29, CD49c,
CD105, and CD147 markers (all .95%), indicating a minimal heterogen-
eity in cell population. Normal human fetal osteoblasts (hFOB 1.19) were
obtained from American Tissue Culture Collection (Manassas, VA). Both
BMPCs and hFOB 1.19 cells were grown in Dulbecco’s modiﬁed Eagle’s
medium containing L-glutamine, 15% fetal bovine serum, 1% penicillin/
streptomycin. The cells were maintained at 37C in 5% CO2, harvested with
trypsine/EDTA, and plated on a 22 3 22 mm coverslip at the initial cell
seeding density of 1000 cells/cm2. BMPCs between passages 3–9 were used
for all experiments. Positive control experiments were performed to dif-
ferentiate BMPCs into bone cells using the osteogenic differentiation media
(10 nM dexamethasone, 20 mM b-glycerophosphate, and 50 mML-ascorbic
acid). The molecular markers such as alkaline phosphatase, calcium min-
eralization, and osteocalcin were used to verify the proper osteogenic dif-
ferentiation. In addition, reverse transcription-polymerase chain reaction
data conﬁrmed upregulation of osteocalcins and osteopontins (data not
shown).
Conjugation of quantum dots
Monoclonal antiintegrin antibodies (CD49d) were purchased from EMD
Biosciences (La Jolla, CA), and CdSe quantum dots (655-nm emission
wavelength) conjugated with secondary antibody were obtained from the
Quantum Dot Corporation (Hayward, CA). These conjugated quantum dots
were functionalized with the F(ab9)2 fragment of afﬁnity-puriﬁed goat
antibodies and cross-adsorbed against the serum proteins of numerous
species. In a typical experiment, cells were blocked by 1% bovine serum
albumin for 30 min and then incubated with anti-Cd49d antibodies (1:1000
dilution, ﬁnal concentration 103 mg/ml) for 20 min at room temperature.
Cells were washed and integrins were selectively labeled with 0.1 nM
conjugated quantum dots for 20 min.
Microscopy and quantum dot motion analysis
Quantum dot movements on the cell surface were observed with a Nikon
microscope (Eclipse E800) in the ﬂuorescence and differential interference
contrast (DIC) modes. An oil-immersion objective (1003 PlanApo, nu-
merical aperture (NA) ¼ 1.4) was used to image cells and quantum dots. A
ﬁlter cube was custom built to excite the CdSe quantum dots (4556 35 nm),
and emission was detected using a 500-nm long-pass ﬁlter. The excitation
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light source was a 100-W Hg lamp. For each tracking experiment, images
were recorded for ;30 s at 150-ms intervals using a 16-bit charge-coupled
device (CCD) camera (Photometrics, Tucson, AZ). All experiments were
carried out at room temperature.
An image processor (MetaMorph, Molecular Devices, Downingtown,
PA) was used to analyze the dynamics of individual quantum dots. Single
nanocrystals were identiﬁed and conﬁrmed by their blinking behavior,
which is an intrinsic property of single quantum dots (33). The quantum dot
position was tracked with nanometer precision using a cross correlation
tracking algorithm. The cross correlation algorithm estimates the change in
position of a particle by comparing an image to a kernel of a successive
image. The kernel which contains the object being tracked is shifted relative
to the image in one-pixel increments. For each increment, a correlation value
is calculated that describes how well the values in the kernel match those of
the underlying image. At the relative shift where kernel and image are most
similar, a maximum in the calculated correlation matrix is found. This tech-
nique results in a subpixel displacement resolution for the tracked particles.
The accuracy of position detection was determined by either tracking quan-
tum dots immobilized on a glass surface or from analysis of quantum dot
movement on ﬁxed cells.
For each particle, mean-square displacement (MSD) for time interval nDt
was calculated according to the formula:
MSDðnDtÞ ¼ 1
N  n 1 +
Nn1
i¼1
½xðiDt1 nDtÞ  xðiDtÞ2
1 ½yðiDt1 nDtÞ  yðiDtÞ2;
where Dt is the time increment (i.e., 150 ms) between two successive frames,
x and y are coordinates of the particle at speciﬁc times, N is the total number
of frames in the sequence (N¼ 200), 0, n, N/4, and 1, i, (N 1 n)
are positive integers. Three modes of quantum dot-receptor conjugate
motion could be distinguished from the MSD curve: simple diffusion,
conﬁned diffusion, directed diffusion modes—this can be expressed as a
power law in the form of MSD¼ 4D(t)t, where the time-dependent diffusion
coefﬁcient is modiﬁed to read D(t) ¼ c t (a1). For Brownian diffusion
(i.e., a ¼ 1), MSD satisﬁes a simple relationship:
MSDðnDtÞ ¼ 4DnDt:
However, the microscopic diffusion coefﬁcient D that is proportional
to the slope of an MSD versus Dt plot near Dt ¼ 0 can be determined
independent of the mode of motion. Fitting a few initial data points (n # 4)
of each MSD plot to a straight line yielded the microscopic diffusion
coefﬁcientD reported in this work and other previously published work (34).
When the time interval is longer than 4Dt (n. 4), signiﬁcant deviation from
the straight line can be observed, for example, in the case of anomalous
diffusion (e.g., restricted or directional motion).
Laser optical tweezers manipulation
Fluorescent polystyrene beads of 0.5-mm diameter (FluoSpheres, 515 nm
emission, Molecular Probes, Eugene, OR) were conjugated with mouse anti-
Cd29 monoclonal antibodies following standard procedure (35). The CD29
molecules are more abundantly expressed on BMPCs (36) and therefore
provide a convenient molecular handle to attach and optically grab sub-
micron beads. After incubation with cells, the membrane-attached particles
were optically trapped and moved away from the cell to extract a tether from
the cell membrane (see Titushkin and Cho (40) for a more detailed de-
scription). The LOT consisted of an Nd:YAG laser beam (1064 nm, 5 W
maximum output power) that was focused with an oil-immersion micro-
scope objective (1003 /NA ¼ 1.4) and translated in the specimen plane at
constant speed 0.5–1.5 mm/s. Bead thermal ﬂuctuations were measured to
calibrate LOT stiffness using the equipartition theorem (37). Fluorescent
images of trapped beads were recorded with a CCD camera at a 10-Hz frame
rate. The tether growth was observed until the bead escaped from the trap
and quickly returned to the original position. The bead position was tracked
with the MetaMorph image processor, and its displacement from the trap and
corresponding optical force were calculated. Typically, 35–40 beads from
;20 cells were analyzed.
RESULTS
Identiﬁcation of integrin clusters and quantum
dot-conjugated integrins
Confocal ﬂuorescence microscopy was used to determine the
integrin distribution on the cell surface. Using FITC-conju-
gated integrin antibodies, integrins (e.g., CD49d) on human
osteoblasts were found to be uniformly distributed (Fig. 1 A).
In contrast, integrin distribution on the surface of undiffer-
entiated BMPCs was much different. First, integrins were
nonuniformly expressed and found in punctates (Fig. 1 B).
Presumably, some of the integrin clusters could represent
focal contact sites that are not typically found in terminally
differentiated cells (e.g., osteoblasts). Third, because the
membrane protein punctates are usually associated with
lateral immobility within the plane of the cell membrane, the
integrin cluster formation provided a clue that the integrins
on the surface of undifferentiated BMPCs may be laterally
conﬁned or restricted.
Selective integrins on the surface of BMPCs were iden-
tiﬁed and visualized using quantum dots that were conju-
gated with antibodies. Fig. 2 illustrates a composite of images
showing the typical BMPC morphology and CdSe quantum
dots conjugated with monoclonal integrin antibodies to pref-
erentially label the a4b1 integrin complex. The primary anti-
bodies were diluted by 1:1000, and 0.1 nM of the quantum
dot-conjugated secondary antibodies were used. This label-
ing protocol was sufﬁcient and allowed us to label and iden-
tify ,20 quantum dot-conjugated integrin molecules per
cell. Because the cell density has been found to be a critical
FIGURE 1 Confocal ﬂuorescence images of integrin distribution on the
surface of human osteoblast (left panel) and BMPC (right panel). Integrins
were visualized using FITC-conjugated anti-CD49d antibodies. Integrins on
the osteoblast were uniformly distributed. In contrast, integrins on the
BMPC were found to cluster in punctates. Images were recorded using a
603/NA ¼ 1.4 microscope objective.
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factor that can inﬂuence BMPC differentiation (31,32),
BMPCs were plated at a low density (1000 cells/cm2) to
ensure that the intended osteogenic differentiation is opti-
mized (32).
Measurement calibration
Quantum dot-conjugated integrin motion was monitored on
the cell surface. Fig. 3, A and B, shows typical trajectories of
integrin movement in osteoblasts or BMPCs at day 1, re-
spectively. Unlike the micrometer-scale movement observed
in tracking an integrin on the surface of osteoblasts (Fig. 3
A), the integrin movement in BMPCs was found to be
severely restricted (Fig. 3 B). Based on these two trajectories,
MSD values were computed, as described in the Materials
and Methods section, and plotted as a function of time. Con-
sistent with the trajectories, the integrin in osteoblasts was
found to execute a conﬁned movement (Fig. 3 C; diamonds)
that spanned a few micrometers in the x and y axes. How-
ever, many integrin molecules observed and tracked in
BMPCs were found to be laterally immobile (Fig. 3 C; tri-
angles). In addition, the ﬁrst four data points (e.g., t, 0.6 s)
in the MSD curve were ﬁtted to a line, and the microdiffusion
coefﬁcient was calculated from the slope of the line (34). To
determine the precision of our tracking technique, cells were
ﬁxed and the integrin diffusion coefﬁcient was measured to
be 7.5 6 4.1 3 1012 cm2/s (n ¼ 20). Therefore, an integrin
movement that showed a diffusion coefﬁcient,1011 cm2/s
was considered laterally immobile.
FIGURE 2 Composite overlay of DIC and ﬂuorescence images. A typical
DIC image of the BMPC was superimposed with a ﬂuorescence image of
integrins visualized using conjugated quantum dots (red) indicated by
arrows. Optimization of antibody dilution (103 mg/ml) and quantum dot
concentration (0.1 nM) resulted in labeling,20 integrin molecules per cell.
Images were recorded using a 1003/NA ¼ 1.4 microscope objective.
FIGURE 3 Typical integrin tracking
experiment. Quantum dot-conjugated
integrins were tracked for 30 s at 150-ms
intervals on the cell surface. Repre-
sentative trajectories of integrins mon-
itored on the surface of human
osteoblast (A) and BMPC (B) show
that the integrin executed a conﬁned
movement in the terminally differenti-
ated osteoblast (C, diamonds) but was
found laterally immobile in BMPC (C,
triangles). The ﬁrst four data points in
the integrin-conﬁned movement were
used to calculate the microdiffusion
coefﬁcient reported in this work (solid
line).
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Integrin dynamics at different stages of
osteogenic differentiation
To test the hypothesis that integrins undergo altered protein
dynamics at later stages of BMPC osteogenic differentiation,
BMPCs were incubated in the osteogenic differentiation me-
dia for 1, 3, 7, and 14 days, and the integrin diffusion was
determined. For comparison, a parallel set of experiments
was performed using human osteoblasts. Fig. 4 A shows
histograms of integrin diffusion coefﬁcients determined on
the surface of terminally differentiated osteoblasts. In all four
histograms constructed for integrin diffusion in human oste-
oblasts, no statistically signiﬁcant changes were detected
during the 14-day observation. Most integrins were shown to
diffuse on the surface of human osteoblasts with a typical
diffusion coefﬁcient in the range of 1–53 1010 cm2/s. This
ﬁnding is consistent with the integrin diffusion coefﬁcient
determined using conventional techniques (e.g., FRAP) (2,38).
In contrast, integrins on the BMPC surface on day 1 were
signiﬁcantly less mobile (Fig. 4 A). For example, ;65% of
integrins diffused with a diffusion coefﬁcient ,3 3 1011
cm2/s, suggesting that integrins at an early stage of os-
teogenic differentiation are conﬁned either physically or by
strong molecular interactions with cytoskeleton. Laterally
restricted integrins appeared to have been freed from the
mobility constraints and became increasingly mobile at the
later stages of osteogenic differentiation, however. After a
3-day incubation in the osteogenic differentiation media, the
diffusion coefﬁcient histogram has shifted to the right, and
.70% of integrins were found to move with a diffusion
coefﬁcient in the range of 1–5 3 1010 cm2/s (Fig. 4 A),
which is similar to the diffusion coefﬁcients for human
osteoblasts. An additional incubation time in the osteogenic
differentiation media did not further increase the integrin
diffusion. After 7–14 days of osteogenic BMPC differenti-
ation, no statistically signiﬁcant increases in the integrin
diffusion coefﬁcient were observed (Fig. 4 B). To ensure that
the osteogenic factors (e.g., dexamethasone) do not directly
affect the integrin diffusion, two control experiments were
performed. First, human osteoblasts were incubated in the
osteogenic differentiation media for 3 days. The integrin
diffusion in fully differentiated osteoblasts in the presence
of the osteogenic factors was unaltered (Fig. 5 A). Second,
BMPCs were incubated in the regular media without the
osteogenic factors for 3 days. As shown in Fig. 5 B, integrins
were found essentially immobile or diffused very slowly.
FIGURE 4 Histograms of integrin
diffusion coefﬁcients. After incubation
of osteoblasts in the normal growth me-
dia for 1, 3, 7, and 14 days, the integrin
diffusion coefﬁcients were measured
and histograms were constructed. To
construct a histogram, at least 20 quan-
tum dot-conjugated integrins from 3–5
osteoblasts and at least 50 integrins
from 30 BMPCs were monitored, and
their diffusion coefﬁcients were deter-
mined as described in the Materials and
Methods section. Histograms of integrin
diffusions on human osteoblasts or
BMPCs were constructed at early dif-
ferentiation stages (e.g., ,3 days; (A))
and at later stages (e.g., .7 days; (B)).
For osteoblasts, the integrin diffusion
coefﬁcients did not statistically differ
between the values determined at day
1 with those at day 3 (p ¼ 0.59), day 7
(p ¼ 0.85), and day 14 (p ¼ 0.38). For
BMPCs, the integrin diffusion coefﬁ-
cients became signiﬁcantly greater after
a 3-day incubation in the osteogenic
media (p , 0.01) but did not further
increase upon longer incubation (e.g., 7
or 14 days).
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These control experiments suggest that altered integrin dy-
namics is likely due to cellular and molecular changes in
response to osteogenic differentiation but not inﬂuenced di-
rectly by the osteogenic factors.
Role of microﬁlaments
Actin microﬁlaments are one of the most important struc-
tural components of the cell cytoskeleton, which determines,
to name a few, the cell shape, mobility, and mechanical prop-
erties, and membrane protein dynamics. Indeed, the com-
partmental model of the cell membrane (39) suggests that the
microﬁlament structures and organization are critically in-
volved in the membrane protein diffusion. To determine the
role of microﬁlaments regulating integrin diffusion, cells
were treated with cytochalasin D to disrupt microﬁlament
organization. Microﬁlaments in human osteoblasts showed
both stress ﬁbers and a network of interconnected microﬁl-
aments (Fig. 6 A). In contrast, microﬁlaments in BMPCs
were organized primarily in thicker stress ﬁbers but lacked
formation of a cytoskeletal network (Fig. 6 B), suggesting
that the membrane-cytoskeleton association that may govern
the integrin dynamics may be cell type dependent. In re-
sponse to cytochalasin D treatment, the microﬁlament stress
ﬁbers disappeared both in human osteoblasts and BMPCs
(data not shown). Integrin diffusion measurements at day
1 showed that, in response to cytochalasin D treatment,
integrins were found to diffuse rapidly in human osteoblasts
(Fig. 6 C) and also in BMPCs (Fig. 6 D). Therefore the
microﬁlament disruption relaxed the integrin mobility con-
straints and increased the integrin diffusion. Indeed, the
integrins were found to diffuse at rates ;10 times greater
than that observed without cytochalasin D treatment. These
ﬁndings indicate that integrin dynamics is closely associated
with and regulated by microﬁlaments in both terminally
differentiated cells and BMPCs.
Membrane-cytoskeleton association
Finally, using LOT, the membrane-cytoskeletal association
was quantitatively assessed. This is rather important because,
in addition to the actin-based cytoskeletal organization, the
molecular association of cell cytoskeleton with the cell mem-
brane may depend on the cell type (40) and because the
membrane protein dynamics may be regulated by differential
membrane mechanics. The latex beads, conjugated with
antiintegrin antibodies, were optically trapped and extended
to form tethers (Fig. 7). The speciﬁcity of beads binding to
b1-integrin subunits was tested with similar but not coated
beads. Beads not conjugated with antibody demonstrated
very low levels of binding to the cells, suggesting high
binding speciﬁcity for antibody-coated probes. As shown in
Fig. 8, the average length of tethers extracted from BMPC
was 10.6 6 1.1 mm, whereas osteoblasts showed a much
lower average tether length (4.0 6 1.2 mm). Our previous
ﬁndings suggest that this difference is due to different
membrane-cytoskeleton interactions in stem cells and fully
differentiated cells (40). For example, when treated with
cytochalasin D to disrupt microﬁlaments, the tether lengths
in fully differentiated cells increased by three- to fourfold,
whereas this same treatment had no effect in the tether length
in BMPCs. It appears that the BMPC cytoskeleton is weakly
associated with the cell membrane and that membrane
mechanical properties are not altered signiﬁcantly by mi-
croﬁlament reorganization, whereas the integrin diffusion is
dictated by the physical and molecular linkage to the
microﬁlaments.
DISCUSSION
Using SPT, we have monitored and determined the quantum
dot-conjugated integrin molecules on the surface of BMPC
and also terminally differentiated human osteoblasts. By
optimizing the antibody concentrations, limited but selective
binding and identiﬁcation of integrins (e.g., ;20 integrins
per cell) on the cell surface has been demonstrated. SPT an-
alyses show that integrins on the surface of undifferentiated
FIGURE 5 Effect of osteogenic factors on integrin diffusion.Human osteo-
blasts were incubated for 3 days in the osteogenic media, and the integrin
diffusion coefﬁcients were measured (A). Similarly, BMPCs were incubated
for 3 days in the normal growth media, and the integrin diffusion coefﬁcients
were measured (B). These treatments did not affect or alter the integrin
diffusion characteristics. The osteogenic factors do not have direct effects on
the integrin diffusion. Each histogram represents data for 20–50 individual
quantum dots tracked from ﬁve osteoblasts and 10 BMPCs.
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BMPCs either diffuse slowly or are immobile. In response to
the osteogenic differentiation, integrins are observed to dif-
fuse more rapidly at the different stages of BMPC osteogenic
differentiation. For example, after a 3-day incubation in the
osteogenic differentiation media, the integrin diffusion char-
acteristics become similar to those found in the terminally
differentiated human osteoblasts. Longer incubation with the
osteogenic factors did not further increase the integrin dif-
fusion, however. As anticipated, integrin dynamics in both
human osteoblasts and BMPCs was regulated by the mi-
croﬁlament organization. Based on the LOT experiments, the
BMPC membrane was found to be weakly coupled with
actin cytoskeleton, suggesting that the membrane protein dy-
namics is regulated largely by the cytoskeletal organization,
and the cellular mechanics plays a minor role. Collectively,
these ﬁndings indicate that the integrin lateral mobility on the
surface of undifferentiated BMPC is severely constrained by
microﬁlaments that appear to relax at later stages of BMPC
differentiation and therefore may be correlated with BMPC
differentiation.
Unlike conventional techniques (e.g., FRAP) that were
developed to measure the molecule movement over a mi-
crometer scale, SPT is capable of determining the micro-
scopic diffusion coefﬁcients of the membrane molecules.
Based on SPT experiments using the quantum dots conju-
gated with integrin antibodies, integrins in the human oste-
oblast membrane show the typical diffusion coefﬁcients in
the range of 109–1010 cm2/s (Fig. 4 A). The characteristic
distance traversed by an integrin molecule during a 0.6-s
measurement time period (i.e., the ﬁrst four data points in the
MSD curve) would be ;340 nm (assuming D ¼ 5 3 1010
cm2/s). This value is less than the typical domain size, which
has been determined to be;500 nm (34), suggesting that an
integrin molecule is unlikely to hop from one domain over to
the next domain during this time of observation. Therefore,
the measurements of integrin diffusion coefﬁcient in this
study can be considered to represent the microscopic integrin
dynamics. Extending the integrin movement trajectories over
10 s, random and conﬁned movements can be distinguished
based on the MSD analysis. For example, the random move-
ment would correlate with a linear increase in MSD, whereas
FIGURE 6 Actin cytoskeleton orga-
nization in osteoblasts (A) and BMPCs
(B). BMPCs are typically bigger in size
than osteoblasts and contain thicker ac-
tin stress ﬁbers with no noticeable actin
network that can be seen in osteoblasts.
When microﬁlaments were disrupted
using cytochalasin D, the integrins were
found to diffuse more rapidly both in
osteoblasts (C) and BMPCs (D). These
two histograms of the integrin diffusion
coefﬁcients are statistically indistin-
guishable (p ¼ 0.83). However, when
compared to the control, the diffusion
coefﬁcient distributions were statisti-
cally different (p ¼ 0.02 for osteoblasts
and p , 0.01 for BMPCs). Each
histogram represents data for at least
20 individual quantum dots tracked
from 3–5 cells at day 1.
FIGURE 7 Membrane tethers extracted from osteoblasts (A) and BMPCs
(B). Fluorescent beads (0.5-mm diameter) were attached to the cell mem-
brane and pulled away from the cell by LOT. The thin membrane tethers
extending from the beads to the cell body (white arrows) appear as faint
shadows in the superimposed brightﬁeld/ﬂuorescence images.
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the conﬁned movement would cause the MSD curve to
saturate (see Fig. 3). At day 1, ;55% and 95% of integrins
monitored in the membrane of osteoblasts and BMPCs
showed the conﬁned movement, respectively. After a 3-day
incubation in the osteogenic media, 65% of integrins in the
BMPC membrane were quantiﬁed to execute the conﬁned
movement. Therefore, in addition to achieving the typical
diffusion coefﬁcient in the membrane of BMPCs, the frac-
tion of integrins freed from the lateral mobility constraints
and able to diffuse also became comparable to that found in
the terminally differentiated osteoblasts.
In intact cell membranes, integrins are known to diffuse at
rates on the order of 109 to 1010 cm2/s (41,42), whereas
lipids or lipid-linked proteins diffuse at faster rates (108
to109 cm2/s) (38,43), suggesting that the typical membrane
proteins are conﬁned or constrained by molecular interac-
tions. At least three mechanisms could be involved to restrict
the integrin mobility constraints on the BMPC surface. First,
integrins may be clustered, thus unable to diffuse in the cell
membrane. Fluorescent images recorded using ﬂuorescently
conjugated integrin antibodies (Fig. 1) show that the initial
distribution of integrins on the BMPC surface at day 1 is
nonuniform and localized in visible integrin punctates, indi-
cating that integrin clusters are likely present. Receptor
clustering alone, however, may not bear signiﬁcant effects
on the receptor diffusion (44). Second, based on the ﬁndings
that integrins are essentially immobile, integrins could inter-
act directly with the cytoskeleton. This postulate is supported
by the ﬁndings that treatment of BMPCs with cytochalasin D
causes integrins to diffuse more rapidly (Fig. 6). Third, the
membrane protein mobility constraints can be adequately
explained by a model in which the cell membrane is com-
partmentalized by the cytoskeletal organization (45). This is
sometimes referred to as the fence model, where the recep-
tor diffusion is restricted within the membrane domains
determined by underlying cytoskeleton (34). Inside these
domains, molecules move with microscopic diffusion coef-
ﬁcient around 5 3 1010 cm2/s. However, whereas the
microﬁlament organization in human osteoblasts appears to
be compartmentalized (see Fig. 6 A), the similar cytoskeletal
arrangement is not clearly observed in BMPCs. For example,
the microﬁlaments in BMPCs (Fig. 6 B) exhibit thicker stress
ﬁbers and the lack of an interconnected network, which
would suggest the BMPC cytoskeletal organization in the
undifferentiated state differs from that observed after dif-
ferentiation. This observation is consistent with recently
reported ﬁndings (30) that BMPCs undergo considerable
morphological and microﬁlament reorganization as these
cells differentiate. Rather than sterically conﬁned in the mi-
croﬁlament-based membrane compartments (e.g., fence
model), the restricted integrin’s lateral mobility in BMPCs
appears to be unique to undifferentiated progenitor cells and
is likely due to physical integrin-microﬁlament attachments.
These molecular constraints are likely responsible for laterally
much lessmobile integrins in the undifferentiated BMPCmem-
brane. However, we cannot completely rule out the possi-
bility that our observations could, in part, be attributed to the
heterogeneity of the BMPC populations.
Furthermore, in terminally committed cells (e.g., osteo-
blasts or ﬁbroblasts), the plasma membrane may be strongly
associated with the underling meshwork of thin actin ﬁbers
through multiple weak links such as lipid-protein bonds (40).
Because the membrane receptor diffusion is regulated by
steric hindrance imposed by the underlying cytoskeletal
structure, integrins can diffuse rapidly within the membrane
domains formed by the actin meshwork and diffuse across
from one domain to anther. In contrast, in progenitor cells,
thick actin stress ﬁbers are connected with the membrane
only at a few discrete sites (e.g., focal adhesions). Weaker
but multiple attachments of intracellular structural proteins
to the lipid bilayer surface in osteoblasts could result in a
stronger membrane-cytoskeleton adhesion in comparison
with stronger but fewer contacts between the membrane and
cytoskeleton in the progenitor cells. A minimal effect of
cytoskeleton disintegration on the membrane tether length
suggests a much weaker membrane-cytoskeleton association
in BMPCs. In agreement with SPT results, the integrin
clusters that may be directly linked to the microﬁlaments
FIGURE 8 Tether extraction experi-
ment. The motion of the laser tweezers
with the trapped bead continued at con-
stant speed 1.5 mm/s until the bead
escaped and quickly retracted to the cell
surface.The tether lengthwasdetermined
from images recorded at 0.1-s intervals.
At day 1, the tether lengths in osteoblasts
and BMPCs were determined. The opti-
cal forces applied to produce these tethers
were estimated to be between 3 and 10
pN. The tether length distributions, con-
structed from measurements of 35–40
tethers (n ¼ 20–25 cells), show that
longer tethers could be produced more
frequently in undifferentiated BMPCs,
indicating a weaker cell membrane-cyto-
skeleton association.
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would be laterally immobile despite a weaker membrane-
cytoskeletal attachment.
Finally, osteogenic differentiation is typically veriﬁed by
using numerous cellular and molecular markers such as
alkaline phosphotase, calcium mineralization, and osteocal-
cin. Some of these markers do not appear until ;10 days
after osteogenic differentiation, however (46,47). A 3-day
incubation of BMPCs with the osteogenic factors is perhaps
too premature to be categorized as speciﬁc osteogenic
differentiation. This observation may be important because
relaxation of integrin mobility constraints may be correlated
with but not sufﬁcient to induce BMPC differentiation into
speciﬁc tissue lineages. This postulate is supported by the
results that integrins remain laterally immobile in BMPCs
when the cells were not treated with the osteogenic factors
and that the osteogenic factors do not affect the integrin
dynamics in terminally differentiated osteoblasts (Fig. 5).
Rather, it appears that laterally mobile integrins are one of
the early biophysical events that are involved in BMPC
proliferation and differentiation. However, it remains to be
determined whether relaxation of the membrane protein
lateral mobility is speciﬁc to the osteogenic differentiation or
whether removal of such biophysical constraints may be
applicable to BMPC differentiation into other tissue lineages.
SUMMARY
The combined use of quantum dot-conjugated molecules and
SPT is a powerful biophysical technique to elucidate the
physical constraints on the protein mobility at the cell sur-
face. Our ﬁndings show that there is a major shift in the
integrin mobility from the undifferentiated BMPC mem-
brane to different stages of BMPC differentiation. Unlike the
typical integrin diffusion found at the later stages of oste-
ogenic differentiation, the integrins in undifferentiated BMPCs
are found to diffuse slowly. After a 3-day differentiation, the
integrin diffusion became no longer distinguishable from
that measured on the terminally differentiated human oste-
oblasts. Future studies of other protein mobility in undiffer-
entiated BMPCs may serve to extend these observations to
other classes of membrane proteins that, like integrins, are
severely constrained by the cytoskeleton (i.e., microﬁla-
ments) yet able to diffuse rapidly in the plane of the mem-
brane under conditions of cytoskeletal reorganization that
could accompany cell differentiation. Finally, when themem-
brane mechanical properties of BMPCs were studied with
the LOTs technique, much longer tethers were extracted
from the BMPC plasma membrane than those from fully dif-
ferentiated osteoblasts, suggesting that differential integrin
dynamics may be attributed to the different membrane me-
chanics. In human osteoblasts, the membrane is tightly
bound to the cytoskeleton, and integrins are conﬁned in the
domains that are deﬁned by the microﬁlament network. In
progenitor cells, however, the distinctive and unusual me-
chanical properties of the cell membrane can be attributed to
its weak attachment to the cytoskeleton (e.g., actins), and
slow integrin diffusion or lateral immobilization are likely
due to direct association of integrins with microﬁlaments.
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